Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis.
Jeyaraman N, Jeyaraman M, Ramasubramanian S, Murugan S, Nallakumarasamy A, Muthu S · World journal of orthopedics · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis.” is organized in H2HUBB under the research focus hydrogen water arthritis musculoskeletal study 2026. The publication is cited as Jeyaraman N, Jeyaraman M, Ramasubramanian S, Murugan S, Nallakumarasamy A, Muthu S, World journal of orthopedics, 2026. This narrative review examined Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis. The abstract describes Published literature review; hydrogen delivered as hydrogen water. The abstract reports: Preclinical models consistently showed reductions in reactive oxygen species, inflammatory cytokines, and improved cell viability. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen water arthritis musculoskeletal study 2026 overview
This review critically evaluates preclinical and clinical evidence for H therapy and identifies research gaps. A review depends on the quality, comparability, and risk of bias of the studies it includes; it does not create stronger evidence than the underlying research.
Study design and hydrogen intervention
Publication type: Narrative review. Evidence type: Review or synthesis. Research model or population: Published literature review. Randomized: Yes. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen water.
Reported findings and scientific interpretation
For this hydrogen water arthritis musculoskeletal study 2026, the study record reports the following: The abstract reports: Preclinical models consistently showed reductions in reactive oxygen species, inflammatory cytokines, and improved cell viability.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Review conclusions depend on the quality, consistency, and heterogeneity of the included studies.
Common limitations included small sample sizes, short durations, and protocol heterogeneity.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.